This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
Human reproduction (Oxford, England), 39(3), 526-537
Citation
Becker, Christian M; Johnson, Neil P; As-Sanie, Sawsan; Arjona Ferreira, Juan C; Abrao, Mauricio S; Wilk, Krzysztof; Imm, So Jung; Mathur, Vandana; Perry, Julie S; Wagman, Rachel B; Giudice, Linda C. (2024). Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.. Human reproduction (Oxford, England), 39(3), 526-537. https://doi.org/10.1093/humrep/dead263